Unilabs, a leading international provider of diagnostic services, has acquired ADUS Radiologie, a radiology company with three centres in Dielsdorf, Kloten, and Affoltern am Albis. This strategic move follows the successful integration of RIMED, acquired
Tags :Lenz & Staehelin
PQ, a global producer of silicates, silicas and derivate products and headquartered in the US, has acquired the specialty silicate business of Swiss-based vanBaerle Group. The Swiss group is a leading manufacturer of high-grade silicates,
Fahrzeug-Werke LUEG, one of the largest mobility providers in Germany and a renowned sales and service partner of the Daimler group, has acquired the Mercedes-Benz dealership Elite Autocenter in Wilderswil near Interlaken, in the canton
Lenz & Staehelin strengthens its ranks with new appointments to be effective as of 1 January 2024. Anja Affolter Marino and Rébecca Dorasamy become new partners of the firm. Five associates have also been promoted to
Vail Resorts has revealed plans to acquire an 84% ownership stake in Remontées Mécaniques Crans Montana Aminona (CMA), the entity managing the renowned Crans-Montana Mountain Resort in Switzerland. This acquisition includes an 80% ownership share
Bär & Karrer advises Miele o the Establishment of a Joint Venture in the Fields of Infection Control and Life Science Miele and Metall Zug have reached an agreement outlining the establishment of a
In a groundbreaking move, the City of Geneva revealed its venture into the green bonds arena, successfully raising an impressive CHF 140 million in aggregate principal amount. This marks the City’s inaugural foray into green
In a strategic move to advance innovation in the Infection Control and Life Science domain, Metall Zug and Miele have inked a transformative agreement. The deal outlines the creation of a new joint venture, where
Competition & Antitrust
Corporate
Lenz & Staehelin: Vencora announces PTO for Crealogix publicly held
Vencora and CREALOGIX, a global player in digital banking technology, jointly announced today that they have entered into a definitive transaction agreement, under which Vencora agreed to submit an all-cash public tender offer to acquire
Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, announced today that it has entered into an asset purchase agreement with Amplyx Pharmaceuticals, an affiliate of Pfizer, to acquire the rights to fosmanogepix, a clinical-stage broad-spectrum antifungal candidate.
